Cancer patients are agreeing to treatment plans lacking a fundamental understanding of the impacts on their finances, explained Ellen Miller Sonet, MBA, JD, chief strategy and policy officer, CancerCare.
Cancer patients are agreeing to treatment plans lacking a fundamental understanding of the impacts on their finances, explained Ellen Miller Sonet, MBA, JD, chief strategy and policy officer, CancerCare.
Transcript
Why is it so important to communicate the financial burden of cancer treatment with patients?
The research that we’ve done suggests that patients don’t know what they’re in for, financially, when they’re making treatment decisions. Consider, for example, buying a car. Would you ever buy a car without knowing the price? Would you buy a refrigerator without knowing the price? Patients are signing on to treatment plans without understanding the financial consequences, and that’s just not right. Both ASCO and the academies of medicine have said that talking about cost is fundamental to shared decision making, high-quality cancer care, and a partnership around doing what’s best for the patient. These kinds of issues have to be explored before treatment decisions are made.
What are best practices for successfully communicating and assisting the patient with these burdens?
The team approach to cancer care is key to making sure that patients really understand the implications of treatment decisions. So, once a physician sees a patient, and they talk about a treatment plan, it’s then really important to sit down and understand how the patient can afford this treatment. We have seen practices where there is a team of navigators, nurses, or financial aid folks that come in and talk to the patients and take them through their co-pays, deductibles, and formulary issues, and help them understand what the impact of treatment will be on their finances.
If that isn’t done, then patients are blind-sided and often suffer the consequences for years. It takes a village. Cancer care is very complex. Patients are overwhelmed with the emotional, physical, spiritual, family, and financial aspects of being sick, and there are many resources that can help support patients on many levels. Patients need to know about them. Providers need to help them understand that these resources exist, and they can make the experience of having cancer less difficult for patients if they know about and avail themselves of these resources.
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Breast Cancer Outcomes Improved in States With Medicaid Expansion
October 24th 2024Medicaid expansion is associated with improved care and increased survival rates for patients with certain breast cancers, but future studies should focus on whether Medicaid expansion mitigates the disparities between Black and non-White patients.
Read More
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
A Look at the Legal and Legislative Landscape Impacting Drug Costs for Patients
October 23rd 2024Kimberly Westrich, MA, of National Pharmaceutical Council, and Adam Colborn, JD, of AMCP, run through the current status of lawsuits and lawmaking at the federal and state levels related to pharmacy benefit managers and cost-shifting programs.
Read More